Ally Bridge Group »

Replimune Group shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Replimune Group (REPL) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Replimune Group

Tip: Access up to 7 years of quarterly data

All positions including Replimune Group held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Replimune Group by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $15M 3.6M 4.19
2025-06-30 $4.9M 529k 9.29

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Replimune Group Call Option (REPL)
Madrigal Pharmaceuticals (MDGL)
Compass Pathways Sponsored Ads (CMPS)
Atai Beckley Nv SHS (ATAI)
Ascendis Pharma A/s - Sponsored Adr (ASND)
Lenz Therapeutics (LENZ)
Taysha Gene Therapies Com Shs (TSHA)
Amylyx Pharmaceuticals (AMLX)
Eupraxia Pharmaceuticals (EPRX)
Praxis Precision Medicines I Com New Call Option (PRAX)
Monopar Therapeutics Com New (MNPR)
Arcutis Biotherapeutics (ARQT)
Mind Medicine Mindmed Com New (MNMD)
Tarsus Pharmaceuticals (TARS)

View all positions for Ally Bridge Group

Top funds holding Replimune Group

Baker Bros. Advisors
Rtw Investments
BlackRock
Fcpm Iii Services B.v.
Point72 Asset Management
Ally Bridge Group
Susquehanna International
Vanguard Group
Tang Capital Management
State Street Corporation
Braidwell
Balyasny Asset Management
Readystate Asset Management
Millennium Management
Geode Capital Management

View all funds holding Replimune Group